Ferritin in the antiphospholipid syndrome and its catastrophic variant (cAPS).

Agmon-Levin, N; Rosário, C; Katz, B-S Porat; Zandman-Goddard, G; Meroni, P; Cervera, R; Stojanovich, L; Blank, M; Pierangeli, Ss; Praprotnik, S; Meis, E de; Seguro, L Parente; Ruffatti, A; Pengo, V; Tincani, A; Doria, A; Shoenfeld, Y

Agmon-Levin, N; Rosário, C; Katz, B-S Porat; Zandman-Goddard, G; Meroni, P; Cervera, R; Stojanovich, L; Blank, M; Pierangeli, Ss; Praprotnik, S; Meis, E de; Seguro, L Parente; Ruffatti, A; Pengo, V; Tincani, A; Doria, A; Shoenfeld, Y.

Affiliation

Agmon-Levin N; 1The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Lupus ; 22(13): 1327-35, 2013 Nov.

Article in En | MEDLINE | ID: mdl-24036580

Subject(s)
Key words

CMV; Ferritin; anti-cardiolipin; antiphospholipid syndrome; autoimmunity; catastrophic antiphospholipid syndrome; hyperferritinemia

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiphospholipid Syndrome / Ferritins Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Lupus Journal subject: REUMATOLOGIA Year: 2013 Document type: Article Affiliation country: Israel

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google